Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The invertebrate gamma-aminobutyric acid (GABA)-gated chloride channel is a member of the Cys-loop superfamily of ligand-gated ion channels and serves as the primary mediator of inhibitory neurotransmission in the nervous systems of insects and other invertebrates (Bloomquist, 1996). Upon binding of the neurotransmitter GABA, the channel opens to allow the influx of chloride ions, which hyperpolarizes the postsynaptic neuron and suppresses electrical activity (Buckingham et al., 2005). This receptor is a major target for several classes of insecticides and ectoparasiticides, including phenylpyrazoles like fipronil and the isoxazoline class, such as fluralaner (Casida, 2015). These drugs typically act as non-competitive antagonists that bind to the inner lining of the chloride channel pore, effectively blocking the inhibitory signal and leading to lethal hyperexcitation of the parasite's nervous system (Gassel et al., 2014). While these channels share structural homology with mammalian GABA-A receptors, distinct amino acid sequences in the binding sites provide high selectivity for invertebrate targets, minimizing host toxicity (Raymond-Delpech et al., 2005). However, the widespread use of these chemicals has led to the emergence of resistance, frequently associated with mutations in the RDL (Resistance to dieldrin) gene, such as the A302S substitution (Ffrench-Constant et al., 2000). Understanding the structural biology of these channels is essential for developing next-generation pesticides that overcome existing resistance mechanisms (Nakao, 2017).
Non-competitive antagonism of the chloride channel pore, blocking inhibitory neurotransmission and causing lethal hyperexcitation of the nervous system.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Invertebrate gamma-aminobutyric acid-gated chloride channel (iGABACl) (iGABACl).